Metabolic Cardiovascular Syndrome Clinical Trial
Official title:
Cluster Analysis of the Risk of Metabolic Syndrome in Women for Reproductive Age.
The metabolic syndrome (MetS) is a cluster of clinical indices that signals increased risk
for cardiovascular disease and Type 2 diabetes. Women with polycystic ovary syndrome (PCOS)
were associated with MetS and insulin resistance. Cluster analysis was a useful tool for
identifying groups of women sharing similar metabolic risk factor patterns. Oligomenorrhea,
hyperandrogenism and polycystic ovary morphology were the three major components of PCOS.
Obesity is a main risk factor in metabolic syndrome. the investigators are interesting to
evaluate the relationship between risk of metabolic syndrome and their clinical and/or
biochemical characteristics in women with reproductive age.
Design: Retrospective study; medical records reviewed. Participants and setting: The
investigators retrospectively reviewed the medical records of female patients who visited our
Reproductive Endocrinology Clinic from Jan. 1, 2009 to Jun. 31, 2012.
Definitions of the metabolic syndrome based on arbitrary cutoff points for several quantitative variables, where each variable is related linearly to cardiovascular risk. Even consensual definitions differ between international authorities and continue to change. Moreover, such cutoff s should be gender and ethic difference. Cluster analysis is a statistical method base on algorithms, which seek to minimize within-group variation and maximize between-group variation for the clustering variables. This technique is suitable for defining groups, reflecting the natural structure of data without relying on inappropriate arbitrary cutoffs. We conduct this retrospective study to review the medical records of female patients who visited our Reproductive Endocrinology Clinic from Jan. 1, 2009 to Dec. 31, 2012. Cluster analysis was performed in our studied cases to evaluate the correlation between clinical/biochemical characteristic and risk of metabolic risk in women with reproductive age. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT02077179 -
Health Improvement After Pregnancy (HIP) Program Randomized Control Trial
|
N/A | |
| Active, not recruiting |
NCT05843682 -
Technological Innovation in the Virtual Assistance of Patients With Uncontrolled Arterial Hypertension - Hyper 2
|
N/A | |
| Completed |
NCT00943254 -
Metabolic Syndrome Diagnosis and Education Trial
|
N/A | |
| Completed |
NCT01408667 -
Hyperinsulinemic Euglycemic Clamp Protocol
|
Phase 1/Phase 2 | |
| Completed |
NCT02151227 -
Magnesium and Metabolic Syndrome: A Dose-response Meta-analysis
|
N/A | |
| Completed |
NCT02460445 -
Phlebotomy and Polycystic Ovary Syndrome
|
N/A | |
| Recruiting |
NCT02646475 -
Metabolic Effects of Angiotensin-(1-7)
|
Phase 1 | |
| Completed |
NCT02268292 -
Home Bicycle Exercise and Aerobic Capacity
|
Phase 4 |